NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as...

Generics manufacturers call for retention of European registration system, post referendum

Generics manufacturers call for retention of European registration system, post referendum

June 29 2016 Generics medicines manufacturers are calling for Britain to keep the current...

Naloxone guidance updated to include supply to children young people

Naloxone guidance updated to include supply to children young people

June 27 2016 Guidance on naloxone supply has been updated with advice about what to consider when...

Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

June 22 2016 The organisation representing pharmacy owner associations has criticised the lack of...

Consultation on how the Falsified Medicines Directive should be implemented

Consultation on how the Falsified Medicines Directive should be implemented

June 22 2016 A four week consultation has commenced asking how the European Falsified Medicines...

  • NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

    NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

    Wednesday, 29 June 2016 11:46
  • Generics manufacturers call for retention of European registration system, post referendum

    Generics manufacturers call for retention of European registration system, post referendum

    Wednesday, 29 June 2016 11:37
  • Naloxone guidance updated to include supply to children young people

    Naloxone guidance updated to include supply to children young people

    Tuesday, 28 June 2016 13:48
  • Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

    Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

    Wednesday, 22 June 2016 14:27
  • Consultation on how the Falsified Medicines Directive should be implemented

    Consultation on how the Falsified Medicines Directive should be implemented

    Wednesday, 22 June 2016 14:16

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

mushroomsJune 1 2016

There will be ongoing educational and treatment activities to prevent harmful drug use, including about the former ‘legal highs’, the Government has indicated.

Announcing that the Psychoactive Substances Act 2016 has now come into force, the Home Office said: “Legislation alone is not the silver bullet, and alongside the Psychoactive Substances Act we continue to take action across education, prevention, treatment and recovery in order to reduce harmful drug use. This includes:

  • providing tools and information for those in the education sector to engage with young people to tackle the use of psychoactive substances
  • working with local areas to help them prevent and respond to the use of psychoactive substances
  • highlighting the risk of these substances to around 50 music festivals
  • publishing clinical guidelines to aid in the detection, assessment and management of users.”

There have been concerns about how the Act will be interpreted, with its “blanket ban on the sale, supply, importation and exportation of the dangerous drugs applying across the UK whenever they are intended for human consumption.” However, “a world-leading testing programme to determine whether a substance is capable of having a psychoactive effect will help provide evidence to support enforcement action.” In addition, there are concerns that the ban will lead to more drugs deaths.

Drugs excluded by the Act are:

  • Controlled Drugs (as defined by the Misuse of Drugs Act 1971)
  • medicinal products
  • alcohol (ethanol) products not containing any psychoactive substance
  • nicotine and tobacco products
  • caffeine
  • any substance which is ordinarily consumed as food or drink and does not contain a prohibited ingredient

Health professionals are exempted from the Act if they are acting in the course of their profession.

Chief Scientist for the Royal Pharmaceutical Society Professor Jayne Lawrence has issued advice for the public, saying the drugs “are dangerous and potentially lethal. You don’t know what you are buying, or how strong they might be, meaning harm and overdose are much more likely, especially when these chemicals are injected or combined with alcohol or drugs. Their impact on individuals in terms of illness and addiction can be severe leading to poisoning, mental health problems, emergency hospital admissions and in some cases, death.

“Now they are outlawed, the spurious term ‘legal high’ will no longer give a badge of legitimacy to them or to those who sell them. Some individuals will continue to buy them regardless of the change in the law. What’s needed is better education and awareness around these chemicals combined with accessible treatment and recovery services in order to reduce their use and the harm they cause.”

Links:

Home Office announcement

Psychoactive Substances Act 2016

RPS comment

Legal & Policy News

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as at GP practices, the New NHS Alliance has proposed.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...